rs2019938

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004356.4(CD81):​c.66+3902A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.657 in 152,196 control chromosomes in the GnomAD database, including 34,697 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.66 ( 34697 hom., cov: 34)

Consequence

CD81
NM_004356.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.90

Publications

17 publications found
Variant links:
Genes affected
CD81 (HGNC:1701): (CD81 molecule) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins. This protein appears to promote muscle cell fusion and support myotube maintenance. Also it may be involved in signal transduction. This gene is localized in the tumor-suppressor gene region and thus it is a candidate gene for malignancies. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
CD81 Gene-Disease associations (from GenCC):
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency, common variable, 6
    Inheritance: Unknown, AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.791 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004356.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD81
NM_004356.4
MANE Select
c.66+3902A>G
intron
N/ANP_004347.1P60033
CD81
NM_001425135.1
c.66+3902A>G
intron
N/ANP_001412064.1
CD81
NM_001425137.1
c.66+3902A>G
intron
N/ANP_001412066.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD81
ENST00000263645.10
TSL:1 MANE Select
c.66+3902A>G
intron
N/AENSP00000263645.5P60033
CD81
ENST00000533417.6
TSL:3
c.267+2311A>G
intron
N/AENSP00000435633.2H0YEE2
CD81
ENST00000905044.1
c.66+3902A>G
intron
N/AENSP00000575103.1

Frequencies

GnomAD3 genomes
AF:
0.658
AC:
100010
AN:
152078
Hom.:
34691
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.444
Gnomad AMI
AF:
0.876
Gnomad AMR
AF:
0.642
Gnomad ASJ
AF:
0.788
Gnomad EAS
AF:
0.450
Gnomad SAS
AF:
0.676
Gnomad FIN
AF:
0.646
Gnomad MID
AF:
0.741
Gnomad NFE
AF:
0.796
Gnomad OTH
AF:
0.702
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.657
AC:
100048
AN:
152196
Hom.:
34697
Cov.:
34
AF XY:
0.649
AC XY:
48299
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.444
AC:
18408
AN:
41502
American (AMR)
AF:
0.641
AC:
9807
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.788
AC:
2735
AN:
3470
East Asian (EAS)
AF:
0.450
AC:
2328
AN:
5176
South Asian (SAS)
AF:
0.676
AC:
3266
AN:
4828
European-Finnish (FIN)
AF:
0.646
AC:
6840
AN:
10582
Middle Eastern (MID)
AF:
0.738
AC:
217
AN:
294
European-Non Finnish (NFE)
AF:
0.796
AC:
54172
AN:
68022
Other (OTH)
AF:
0.698
AC:
1476
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1636
3272
4908
6544
8180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
788
1576
2364
3152
3940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.753
Hom.:
146781
Bravo
AF:
0.646
Asia WGS
AF:
0.595
AC:
2073
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.042
DANN
Benign
0.60
PhyloP100
-1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2019938; hg19: chr11-2402747; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.